Variant report
Variant | nsv819435 |
---|---|
Chromosome Location | chr11:102575468-102576590 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:246)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No. | Chromosome Location | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr11:102576374-102576424 | CMK | blood: | n/a |
2 | chr11:102576469-102576519 | A549 | lung: | n/a |
3 | chr11:102576374-102576424 | CMK | blood: | n/a |
4 | chr11:102576469-102576519 | A549 | lung: | n/a |
5 | chr11:102576508-102576558 | Jurkat | blood: | n/a |
6 | chr11:102576469-102576519 | AG04450 | lung: | fetal |
7 | chr11:102576374-102576424 | SAEC | small airway: | n/a |
8 | chr11:102576508-102576558 | HCPEpiC | choroid plexus: | n/a |
9 | chr11:102576374-102576424 | Jurkat | blood: | n/a |
10 | chr11:102576374-102576424 | NH-A | brain: | n/a |
11 | chr11:102576094-102576144 | HRPEpiC | eye: | n/a |
12 | chr11:102576508-102576558 | HAEpiC | amniotic membrane: | n/a |
13 | chr11:102576374-102576424 | HCF | heart: | n/a |
14 | chr11:102576508-102576558 | GM19239 | blood: | n/a |
15 | chr11:102576469-102576519 | HRCEpiC | kidney: | n/a |
16 | chr11:102576508-102576558 | HIPEpiC | eye: | n/a |
17 | chr11:102576094-102576144 | NB4 | blood: | n/a |
18 | chr11:102576508-102576558 | NT2-D1 | testis: | n/a |
19 | chr11:102576469-102576519 | ProgFib | skin: | n/a |
20 | chr11:102576094-102576144 | BJ | skin: | n/a |
21 | chr11:102576374-102576424 | ProgFib | skin: | n/a |
22 | chr11:102576094-102576144 | Hela-S3 | cervix: | n/a |
23 | chr11:102576469-102576519 | Caco-2 | colon: | n/a |
24 | chr11:102576508-102576558 | NB4 | blood: | n/a |
25 | chr11:102576469-102576519 | AG10803 | skin: | n/a |
26 | chr11:102576508-102576558 | HMEC | breast: | n/a |
27 | chr11:102576094-102576144 | LNCaP | prostate: | n/a |
28 | chr11:102576508-102576558 | AG10803 | skin: | n/a |
29 | chr11:102576374-102576424 | GM12878 | blood: | n/a |
30 | chr11:102576469-102576519 | NB4 | blood: | n/a |
31 | chr11:102576508-102576558 | SK-N-MC | brain: | n/a |
32 | chr11:102576374-102576424 | HPAEpiC | pulmonary alveolar: | n/a |
33 | chr11:102576508-102576558 | AG09309 | skin: | n/a |
34 | chr11:102576508-102576558 | SKMC | muscle: | n/a |
35 | chr11:102576508-102576558 | SAEC | small airway: | n/a |
36 | chr11:102576508-102576558 | ovcar-3 | ovarian: | n/a |
37 | chr11:102576094-102576144 | Jurkat | blood: | n/a |
38 | chr11:102576508-102576558 | HEK293 | kidney: | embryo |
39 | chr11:102576094-102576144 | HNPCEpiC | eye: | n/a |
40 | chr11:102576374-102576424 | PANC-1 | pancreas: | n/a |
41 | chr11:102576469-102576519 | GM06990 | blood: | n/a |
42 | chr11:102576508-102576558 | MCF-7 | breast: | n/a |
43 | chr11:102576094-102576144 | H1-hESC | embryonic stem cell: | embryo |
44 | chr11:102576374-102576424 | SK-N-SH_RA | brain: | n/a |
45 | chr11:102576469-102576519 | BE2_C | brain: | n/a |
46 | chr11:102576469-102576519 | PANC-1 | pancreas: | n/a |
47 | chr11:102576094-102576144 | HRCEpiC | kidney: | n/a |
48 | chr11:102576469-102576519 | SK-N-MC | brain: | n/a |
49 | chr11:102576469-102576519 | PFSK-1 | brain: | n/a |
50 | chr11:102576469-102576519 | HepG2 | liver: | n/a |
No data |
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
MMP27 | CpG island |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs199822515 | chr11:102575508-102575509 | Active TSS Flanking Active TSS Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs369611444 | chr11:102575518-102575519 | Active TSS Flanking Active TSS Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs144957816 | chr11:102575531-102575532 | Active TSS Flanking Active TSS Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs371458210 | chr11:102575554-102575555 | Active TSS Flanking Active TSS Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs149024054 | chr11:102575574-102575575 | Active TSS Flanking Active TSS Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs191928271 | chr11:102575599-102575600 | Active TSS Flanking Active TSS Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs79750859 | chr11:102575615-102575616 | Flanking Active TSS Active TSS Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs398097782 | chr11:102575618-102575619 | Flanking Active TSS Active TSS Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs113764420 | chr11:102575619-102575620 | Flanking Active TSS Active TSS Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs535441360 | chr11:102575655-102575656 | Flanking Active TSS Active TSS Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs73590685 | chr11:102575694-102575695 | Flanking Active TSS Active TSS Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
12 | rs572622507 | chr11:102575695-102575696 | Flanking Active TSS Active TSS Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs11225388 | chr11:102575739-102575740 | Flanking Active TSS Active TSS Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
14 | rs12279227 | chr11:102575754-102575755 | Flanking Active TSS Active TSS Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
15 | rs372370170 | chr11:102575776-102575777 | Flanking Active TSS Active TSS Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs184398383 | chr11:102575782-102575783 | Flanking Active TSS Active TSS Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs543702801 | chr11:102575800-102575801 | Flanking Active TSS Active TSS Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs563361904 | chr11:102575831-102575832 | Flanking Active TSS Active TSS Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs573816576 | chr11:102575907-102575908 | Flanking Active TSS Active TSS Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs189465336 | chr11:102575930-102575931 | Flanking Active TSS Active TSS Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs143045429 | chr11:102575962-102575963 | Flanking Active TSS Active TSS Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs533268838 | chr11:102576025-102576026 | Flanking Active TSS Active TSS Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs148266536 | chr11:102576095-102576096 | Flanking Active TSS Active TSS Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs181206737 | chr11:102576103-102576104 | Flanking Active TSS Active TSS Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs564884051 | chr11:102576135-102576136 | Flanking Active TSS Active TSS Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs141384840 | chr11:102576152-102576153 | Flanking Active TSS Active TSS Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs530729883 | chr11:102576239-102576240 | Flanking Active TSS Weak transcription Active TSS | n/a | n/a | Overlapped CNVs | n/a |
28 | rs375301646 | chr11:102576250-102576251 | Flanking Active TSS Weak transcription Active TSS | n/a | n/a | Overlapped CNVs | n/a |
29 | rs375874111 | chr11:102576315-102576316 | Flanking Active TSS Weak transcription Active TSS | n/a | n/a | Overlapped CNVs | n/a |
30 | rs200860822 | chr11:102576321-102576322 | Flanking Active TSS Weak transcription Active TSS | n/a | n/a | Overlapped CNVs | n/a |
31 | rs199890406 | chr11:102576343-102576344 | Flanking Active TSS Weak transcription Active TSS | n/a | n/a | Overlapped CNVs | n/a |
32 | rs2846707 | chr11:102576358-102576359 | Flanking Active TSS Weak transcription Active TSS | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
33 | rs375954547 | chr11:102576368-102576369 | Flanking Active TSS Weak transcription Active TSS | n/a | n/a | Overlapped CNVs | n/a |
34 | rs137937370 | chr11:102576373-102576374 | Flanking Active TSS Weak transcription Active TSS | n/a | n/a | Overlapped CNVs | n/a |
35 | rs1939015 | chr11:102576375-102576376 | Flanking Active TSS Weak transcription Active TSS | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
36 | rs12099177 | chr11:102576382-102576383 | Flanking Active TSS Weak transcription Active TSS | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
37 | rs374776742 | chr11:102576385-102576386 | Flanking Active TSS Weak transcription Active TSS | n/a | n/a | Overlapped CNVs | n/a |
38 | rs147720824 | chr11:102576391-102576392 | Flanking Active TSS Weak transcription Active TSS | n/a | n/a | Overlapped CNVs | n/a |
39 | rs140789380 | chr11:102576397-102576398 | Flanking Active TSS Weak transcription Active TSS | n/a | n/a | Overlapped CNVs | n/a |
40 | rs368255009 | chr11:102576412-102576413 | Flanking Active TSS Active TSS Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs566072299 | chr11:102576421-102576422 | Flanking Active TSS Active TSS Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs184904777 | chr11:102576438-102576439 | Flanking Active TSS Active TSS Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs558421984 | chr11:102576439-102576440 | Flanking Active TSS Active TSS Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs11225389 | chr11:102576468-102576469 | Flanking Active TSS Active TSS Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
45 | rs374493970 | chr11:102576469-102576470 | Flanking Active TSS Active TSS Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs189408947 | chr11:102576470-102576471 | Flanking Active TSS Active TSS Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs574047235 | chr11:102576490-102576491 | Flanking Active TSS Active TSS Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs12418360 | chr11:102576493-102576494 | Flanking Active TSS Active TSS Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
49 | rs376342182 | chr11:102576497-102576498 | Flanking Active TSS Active TSS Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs146980600 | chr11:102576531-102576532 | Flanking Active TSS Active TSS Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Medulloblastoma | 21979893 | CNVD |
Gastric cancer | 17908304 | CNVD |
Multiple myeloma | 20724749 | CNVD |
Wilms tumour | 21544195 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Intellectual disability | 22102821 | CNVD |
Autism | 22495311 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Cancer | 21637783 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Chronic lymphocytic leukemia | 21795749 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Neuroblastoma | 21484798 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Oral cancer | 21386901 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 20837533 | CNVD |
Breast cancer | 21264507 | CNVD |
Cervical cancer | 21063398 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Liposarcoma | 21253554 | CNVD |
Neuroblastoma | 18923524 | CNVD |
Neuroblastoma | 18664255 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Neuroblastoma | 17533364 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Cancer | 16751803 | CNVD |
Seminomas | 18059402 | CNVD |
Cervical cancer | 21062161 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Cancer | 22429812 | CNVD |
Breast cancer | 16608533 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Melanoma | 18172304 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Hepatocellular carcinoma | 16785998 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Breast cancer | 21858162 | CNVD |
Breast cancer | 21785460 | CNVD |
Melanoma | 22183965 | CNVD |
Breast cancer | 21958427 | CNVD |
Lung cancer | 18438408 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Renal cell carcinoma | 18194544 | CNVD |
Breast cancer | 17133270 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Acute lymphoblastic leukemia | 21098271 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Breast cancer | 17603634 | CNVD |
T-cell acute lymphoblastic leukemia | 18185524 | CNVD |
Basal cell lymphoma | 16790693 | CNVD |
Chronic lymphocytic leukemia | 21670202 | CNVD |
Breast cancer | 21364760 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Ovarian clear cell carcinoma | 19293255 | CNVD |
Mental retardation | 19966786 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Invasive pancreatic ductal carcinoma | 16982739 | CNVD |
Multiple myeloma | 16616336 | CNVD |
Intracranial aneurysm | 16715129 | CNVD |
Ovine squamous-cell carcinoma | 17599052 | CNVD |
Basal cell lymphoma | 17170743 | CNVD |
Follicular lymphoma | 17170743 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Prostate cancer | 18632612 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Colorectal cancer | 16912164 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Melanoma | 17363583 | CNVD |
Chronic lymphocytic leukemia | 17805327 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Breast cancer | 16397240 | CNVD |
Chronic lymphocytic leukemia | 18922857 | CNVD |
Neuroblastoma | 17327916 | CNVD |
Melanoma | 20877625 | CNVD |
Cancer | 20164919 | CNVD |
Breast cancer | 22522925 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr11:102572600-102579800 | Weak transcription | Primary neutrophils fromperipheralblood | blood |
2 | chr11:102575200-102575600 | Flanking Active TSS | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
3 | chr11:102575400-102575600 | Active TSS | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
4 | chr11:102575400-102576600 | Active TSS | NHDF-Ad | bronchial |
5 | chr11:102575600-102575800 | Enhancers | Foreskin Fibroblast Primary Cells skin01 | Skin |
6 | chr11:102575600-102576000 | Active TSS | Foreskin Fibroblast Primary Cells skin02 | Skin |
7 | chr11:102575600-102576000 | Active TSS | Adipose Nuclei | Adipose |
8 | chr11:102575600-102576200 | Active TSS | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
9 | chr11:102575600-102576600 | Flanking Active TSS | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
10 | chr11:102575800-102576200 | Active TSS | Foreskin Fibroblast Primary Cells skin01 | Skin |
11 | chr11:102576000-102576200 | Flanking Active TSS | Foreskin Fibroblast Primary Cells skin02 | Skin |
12 | chr11:102576000-102576200 | Flanking Active TSS | Adipose Nuclei | Adipose |
13 | chr11:102576200-102576400 | Flanking Active TSS | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
14 | chr11:102576200-102576400 | Active TSS | Adipose Nuclei | Adipose |
15 | chr11:102576400-102576600 | Active TSS | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
16 | chr11:102576400-102576600 | Flanking Active TSS | Adipose Nuclei | Adipose |